Back to MORGAN STANLEY MORGAN STANLEY

GLUEGLUE
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in MONTE ROSA THERAPEUTICS INC

MORGAN STANLEY holds 789,545 shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $19.1M as of 2026-Q2. The position was increased (+15.4% shares). GLUE represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$19.1M

Current Shares

789,545

Total Value Change

+$18.4M

Total Shares Change

+664,213

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
789,545
+15.4%
$19.1M0.0%$24.20
33
2026-Q1
Decreased
684,063
-15.1%
$11.3M0.0%$17.96
0
2025-Q4
Increased
805,530
+24.9%
$12.6M0.0%$15.97
34
2025-Q3
Increased
645,196
+13.1%
$4.8M0.0%$7.31
30
2025-Q2
Increased
570,450
+35.1%
$2.6M0.0%$4.60
34
2025-Q1
Decreased
422,090
-81.3%
$2M0.0%$5.10
0
2024-Q4
Increased
2.3M
+1699.5%
$15.7M0.0%$7.02
45
2024-Q3
Increased
125,332
+83.4%
$664,2600.0%$5.17
26

Other major holders of GLUE: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used